or Try an Advanced Search...

    Technical Analysis for RNA - Avidity Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 45.40 -4.18% -1.98
    RNA closed down 4.18 percent on Wednesday, October 23, 2024, on 58 percent of normal volume.
    Earnings due: Nov 6
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Down
    Historical RNA trend table...
    Date Alert Name Type % Chg
    Fell Below 20 DMA Bearish 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    20 DMA Support Bullish -4.18%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.18%
    Inside Day Range Contraction -4.18%
    Stochastic Sell Signal Bearish -2.80%
    20 DMA Support Bullish -2.80%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.80%
    Slingshot Bullish Bullish Swing Setup -2.80%
    Multiple of Ten Bearish Other -2.80%
    Older End-of-Day Signals for RNA ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 7 hours ago
    Fell Below Previous Day's Low about 9 hours ago
    20 DMA Support about 10 hours ago
    60 Minute Opening Range Breakdown about 10 hours ago
    Down 2 % about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    RNA Chart by TradingView
    Basic chart:

    Profile

    Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Disease Treatment Of Cancer Pharmaceutical Products Biopharmaceutical Products

    Is RNA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 18 Avidity Biosciences, Up 441%, Nears Another Record High As Dystrophy Space Heats Up
    Oct 4 Why Avidity Biosciences Zoomed to a 12% Gain This Week
    Oct 4 FDA lifts clinical hold on Avidity’s lead antibody conjugate therapy trial
    Oct 3 Avidity gets FDA partial clinical hold lifted on DM1 drug candidate
    Oct 3 Avidity Biosciences: Good Prospects, But We Are A Little Late
    Oct 3 Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001)
    Oct 2 Avidity Biosciences: Intriguing Oligonucleotide Program To Monitor Over Longer Term
    Sep 29 Is Avidity Biosciences, Inc. (RNA) the Best Performing Long Term Stock in 2024?
    Sep 26 Is Avidity Biosciences Inc. (RNA) the Best Performing Small-Cap Stock in 2024?
    Sep 5 Avidity Biosciences Joins Patient and Advocacy Communities in Raising Awareness During National Muscular Dystrophy Awareness Month
    See more RNA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 50.78
    52 Week Low 4.825
    Average Volume 1,375,498
    200-Day Moving Average 31.45
    50-Day Moving Average 44.46
    20-Day Moving Average 46.40
    10-Day Moving Average 47.16
    Average True Range 2.52
    RSI (14) 48.45
    ADX 12.44
    +DI 21.23
    -DI 19.85
    Chandelier Exit (Long, 3 ATRs) 43.23
    Chandelier Exit (Short, 3 ATRs) 48.56
    Upper Bollinger Bands 50.45
    Lower Bollinger Band 42.36
    Percent B (%b) 0.38
    BandWidth 17.42
    MACD Line 0.90
    MACD Signal Line 1.01
    MACD Histogram -0.113
    Fundamentals Value
    Market Cap 3.61 Billion
    Num Shares 79.4 Million
    EPS -3.00
    Price-to-Earnings (P/E) Ratio -15.13
    Price-to-Sales 113.02
    Price-to-Book 2.05
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 48.48
    Resistance 3 (R3) 48.76 48.03 47.96
    Resistance 2 (R2) 48.03 47.24 47.88 47.79
    Resistance 1 (R1) 46.71 46.76 46.35 46.43 47.62
    Pivot Point 45.98 45.98 45.79 45.83 45.98
    Support 1 (S1) 44.66 45.19 44.30 44.38 43.18
    Support 2 (S2) 43.93 44.71 43.78 43.01
    Support 3 (S3) 42.61 43.93 42.84
    Support 4 (S4) 42.33